Asset profile
omalizumab-igec · Castor Maritime Inc. (CTRM)
- Indication
- moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), IgE-mediated food allergy, chronic spontaneous urticaria (CSU)
- Also known as
- OMLYCLO, OMLYCLO®
Company
CTRMCastor Maritime Inc.
CTRMCastor Maritime Inc.Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments, na…
On the calendar
Nothing scheduled in this window.
Timeline
Newest first.
More from Castor Maritime Inc.
Other drugs and candidates from the same company tracked in this sector.